Notably, the ratio of the expanded subset of the CD4+CD25hi cells, or CD4+CD25hi CD127low Tregs to CD4+ cells was further determined; GC and CRC patients demonstrated an increase in the ratio as compared to healthy donors (Fig. 2D-E). This evidence concerns the gene CD4 and colorectal carcinoma.